Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Perosphere Technologies has developed the ClotChek™, a novel point-of-care diagnostic device that rapidly measures whole blood clotting times and the pharmacodynamic effects of direct oral anticoagulants using a single drop of blood. The device delivers results within minutes and aims to improve decision-making for diagnosis, treatment, and prevention in coagulation management. The technology has CE Mark approval in Europe but has not yet received FDA clearance in the United States. Clinical validation studies have shown encouraging performance compared to standard methods.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Perosphere Technologies.